Tag:

MD Anderson Cancer Center

Latest Headlines

Latest Headlines

Hologic joins with Metamark to market prostate cancer test; Cepheid inks molecular Dx distribution deal with Henry Schein

In this week's Dx Digest, Hologic struck a deal with cancer diagnostics company Metamark Genetics to market its prostate cancer test, Cepheid is teaming up with Henry Schein Medical to distribute its testing system and related diagnostics, which cover areas including infectious disease and sexual health, and Signal Genetics and MD Anderson are kicking off a new study to see how well Signal's multiple myeloma test can identify patients at risk for their disease worsening.

MD Anderson starts pilot breast cancer study using Apple Watch

Researchers are starting a 9-month study of breast cancer patients using the Apple Watch to capture basic health data alongside treatment information and various aspects of patient health. The study uses an app that was developed by behavioral health tech company Polaris Health.

Top cancer doc takes to social media to fight rising prices

The drug pricing debate has reached a pinnacle as of late, with lawmakers, presidential hopefuls and payers railing against skyrocketing costs. Back in February, when the noise was more of a dull roar, a top cancer doctor joined the growing chorus of discontent, announcing that he would protest cancer drug prices on social media.

Exact Sciences joins forces with MD Anderson for lung cancer Dx development

Exact Sciences is teaming up with the MD Anderson Cancer Center to develop a blood-based diagnostics for lung cancer, looking to expand its offerings past its innovative colorectal cancer screening test and gain some ground in a rapidly growing market.

Exact Sciences joins forces with MD Anderson for lung cancer Dx development

Exact Sciences is teaming up with the MD Anderson Cancer Center to develop a blood-based diagnostics for lung cancer, looking to expand its offerings past its innovative colorectal cancer screening test and gain some ground in a rapidly growing market.

MD Anderson Cancer Center partners to start breast cancer pilot project using Apple Watch

The MD Anderson Cancer Center at Cooper has partnered with behavioral health technology player Polaris Health Directions to start a pilot test using the Apple Watch that integrates patient behavioral data into electronic health records and population health data.

MD Anderson team explores a combination approach against cancer metastasis

Researchers at The University of Texas MD Anderson Cancer Center say they've devised a new strategy for attacking breast cancer tumors before they metastasize.

Fed-up MD Anderson oncologist jumps on social media to fight drug prices

Flush with success in negotiating discounts for hepatitis C drugs, payers are promising to strong-arm drugmakers in other treatment classes, too--cholesterol and cancer, for instance. They'll have more than one oncologist on their sides: A top doctor at the MD Anderson Cancer Center, fed up with cancer drug prices, plans a social media protest.

Amgen teams with MD Anderson on new BiTE programs for MDS

Fast on the heels of the FDA's approval of Blincyto (blinatumomab), Amgen's new leukemia fighter that uses a bispecific T cell engager system to flag cancer cells for the immune system to destroy, the Big Biotech has partnered up with MD Anderson in Texas on a new program aimed at identifying targets for this technology in myelodysplastic syndrome.

Researchers zero in on biomarker for early diagnosis of ovarian cancer

Investigators say that a biomarker in the blood--carbohydrate antigen 125, or CA125--offers a shot at a relatively low-cost approach to identifying ovarian cancer  at an early stage, while the chances of survival are much higher.